Compare PPCB & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PPCB | IBG |
|---|---|---|
| Founded | 2007 | 2018 |
| Country | Australia | Australia |
| Employees | 2 | 9 |
| Industry | | Beverages (Production/Distribution) |
| Sector | | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3M | 1.9M |
| IPO Year | N/A | N/A |
| Metric | PPCB | IBG |
|---|---|---|
| Price | $0.10 | $1.02 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 6.1M | 248.4K |
| Earning Date | 05-16-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.10 | $0.30 |
| 52 Week High | $10.69 | $6.50 |
| Indicator | PPCB | IBG |
|---|---|---|
| Relative Strength Index (RSI) | 41.65 | 36.56 |
| Support Level | N/A | $0.97 |
| Resistance Level | $0.13 | $1.31 |
| Average True Range (ATR) | 0.01 | 0.10 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 21.51 | 6.52 |
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.